Sunshine Biopharma Inc. -27SBFMWPreferred / convertible
13F holders, Q1 2025 (March 31)3holders +1
1new positions
0sold out
1famous investor
$0.20avg. 13F price*
At the end of Q1 2025, 3 institutions reported holding Sunshine Biopharma Inc. -27 (SBFMW) in their 13F filings, up 1 from Q4 2024. 1 opened new positions and 0 sold out. The largest holders were Citadel Advisors ($6K), UBS Group AG ($6K) and Clear Street LLC ($19). One famous investor held it Ken Griffin ( of Citadel Advisors's portfolio).
- Company
- Sunshine Biopharma Inc. -27
- CUSIP
- 867781502
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $19 |
| Exits | 0 | $0 |
All 13F filers, Q4 2024 → Q1 2025: 28,536 shares bought and 10,886 shares sold, net +17,650 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Citadel Advisors | — | Reduce -26.3% | 30,545 | $6K |
| UBS Group AG | — | Add +2206.5% | 29,731 | $6K |
| Clear Street LLC | — | New | 94 | $19 |
"% of holder's portfolio" is SBFMW's weight in each manager's 13F, not the share of Sunshine Biopharma Inc. -27 the manager owns.